Zaid Tafesh
Overview
Explore the profile of Zaid Tafesh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flikshteyn B, Amer K, Tafesh Z, Pyrsopoulos N
Clin Liver Dis
. 2023 Nov;
28(1):37-50.
PMID: 37945161
Autoimmune hepatitis (AIH) presents a diagnostic challenge because it is relatively rare and heterogenous in presentation. This article presents the currently adopted approach to AIH diagnosis and explores the challenges...
2.
Azer A, Kong K, Basta D, Modica S, Gore A, Gorman E, et al.
Am J Surg
. 2023 Sep;
227:34-43.
PMID: 37722936
Background: Cirrhosis causes significant coagulopathy. Traditional coagulation tests may not accurately measure coagulopathy in well-compensated patients with cirrhosis. Viscoelastic tests are functional tests that may better assess coagulopathy in cirrhotic...
3.
Amer K, Flikshteyn B, Lingiah V, Tafesh Z, Pyrsopoulos N
Clin Liver Dis
. 2023 Jun;
27(3):563-579.
PMID: 37380283
No abstract available.
4.
Azer A, Panayotova G, Kong K, Hakakian D, Sheikh F, Gorman E, et al.
J Surg Res
. 2023 Mar;
287:142-148.
PMID: 36933545
Introduction: Thromboelastography (TEG) is a functional test of coagulation used to guide transfusions. Despite literature supporting its utility, its use remains limited to select populations. In patients with cirrhosis, conventional...
5.
Wakil A, Mohamed M, Tafesh Z, Niazi M, Olivo R, Xia W, et al.
World J Gastroenterol
. 2022 Sep;
28(34):5036-5046.
PMID: 36160652
Background: Severe alcoholic hepatitis (AH) is one of the most lethal manifestations of alcohol-associated liver disease. In light of the increase in alcohol consumption worldwide, the incidence of AH is...
6.
Hajifathalian K, Tafesh Z, Rosenblatt R, Kumar S, Homan E, Sharaiha R, et al.
J Clin Gastroenterol
. 2021 Feb;
56(2):173-180.
PMID: 33606428
Background: Indications for use of statins are common among patients with nonalcoholic fatty liver disease (NAFLD). Epidemiologic studies have suggested a possible association between statins and decreased risk of malignancies....
7.
Han M, Yu Q, Tafesh Z, Pyrsopoulos N
J Clin Transl Hepatol
. 2021 Feb;
9(1):71-80.
PMID: 33604257
Globally, the rise in prevalence of obesity and metabolic syndrome as a whole has been linked to increased access to processed foods, such as refined sugars and saturated fats. Consequently,...
8.
Rosenblatt R, Atteberry P, Tafesh Z, Ravikumar A, Crawford C, Lucero C, et al.
Dig Liver Dis
. 2020 Nov;
53(4):445-451.
PMID: 33153928
Background: Diabetes mellitus (DM) is common in patients with cirrhosis and is associated with increased risk of infection. Aim: To analyze the impact of uncontrolled DM on infection and mortality...
9.
Rosenblatt R, Shen N, Tafesh Z, Cohen-Mekelburg S, Crawford C, Kumar S, et al.
Liver Transpl
. 2019 Dec;
26(2):187-195.
PMID: 31785079
Acute-on-chronic liver failure (ACLF) carries high short-term mortality. The North American Consortium for the Study of End-Stage Liver Disease (NACSELD)-ACLF score, positive if ≥2 organ failures are present, is a...
10.
Rosenblatt R, Tafesh Z, Shen N, Cohen-Mekelburg S, Kumar S, Lucero C, et al.
Am J Gastroenterol
. 2019 Nov;
114(12):1863-1869.
PMID: 31688022
Introduction: Symptomatic ascites is the most common indication for hospitalization in patients with cirrhosis. Although guidelines recommend paracentesis for all inpatients with ascites, the timing of paracentesis is likely to...